Synergistic inhibition of growth of triple-negative breast cancer cells by co-targeting PARP and HDAC

被引：0
|
作者：
Marijon, Helene [1 ]
Sun, Haibo [1 ]
de Gramont, Aimery [2 ]
Gery, Sigal [1 ]
Koeffler, H. Phillip [1 ]
机构：
[1] Cedars Sinai Med Ctr, West Hollywood, CA USA
[2] Hop St Antoine, F-75571 Paris, France
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-5542
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5542
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells
    Andrew Sulaiman
    Sarah McGarry
    Ka Mien Lam
    Sara El-Sahli
    Jason Chambers
    Shelby Kaczmarek
    Li Li
    Christina Addison
    Jim Dimitroulakos
    Angel Arnaout
    Carolyn Nessim
    Zemin Yao
    Guang Ji
    Haiyan Song
    Sheng Liu
    Ying Xie
    Suresh Gadde
    Xuguang Li
    Lisheng Wang
    [J]. Cell Death & Disease, 9
  • [22] Targeting PP2A inhibits the growth of triple-negative breast cancer cells
    Uddin, Mohammed Hafiz
    Pimentel, Julio M.
    Chatterjee, Madhumita
    Allen, Joshu E.
    Zhuang, Zhengping
    Wu, Gen Sheng
    [J]. CELL CYCLE, 2020, 19 (05) : 592 - 600
  • [23] Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer
    Beniey, Michele
    Hubert, Audrey
    Haque, Takrima
    Cotte, Alexia Karen
    Bechir, Nelly
    Zhang, Xiaomeng
    Tran-Thanh, Danh
    Hassan, Saima
    [J]. BRITISH JOURNAL OF CANCER, 2023, 128 (10) : 1964 - 1975
  • [24] Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer
    Michèle Beniey
    Audrey Hubert
    Takrima Haque
    Alexia Karen Cotte
    Nelly Béchir
    Xiaomeng Zhang
    Danh Tran-Thanh
    Saima Hassan
    [J]. British Journal of Cancer, 2023, 128 : 1964 - 1975
  • [25] Synergistic inhibition of thioridazine combined with carboplatin on triple negative breast cancer by targeting cancer stem cells
    Wang, Yi
    Xia, Leiming
    Gong, Li
    Xia, Yang
    Liu, Liu
    Liu, Yuanyuan
    Max, Wicha
    Chang, Alfred E.
    Li, Qiao
    Bao, Yangyi
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [26] Dasatinib is synergistic with cetuximab and cisplatin in triple-negative breast cancer cells
    Kim, Elizabeth M. H.
    Mueller, Kelly
    Gartner, Elaina
    Boerner, Julie
    [J]. JOURNAL OF SURGICAL RESEARCH, 2013, 185 (01) : 231 - 239
  • [27] Synergistic chemosensitivity of triple-negative breast cancer cell lines to a PARP inhibitor, cisplatin and gemcitabine
    Hastak, Kedar
    Alli, Elizabeth
    Ford, James
    [J]. CANCER RESEARCH, 2009, 69
  • [28] Judy Garber on PARP inhibitors for triple-negative breast cancer
    Garber, Judy
    [J]. ONCOLOGY-NEW YORK, 2017, 31 (11): : 814 - +
  • [29] Efp promotes growth of triple-negative breast cancer cells
    Sato, Wataru
    Ikeda, Kazuhiro
    Gotoh, Noriko
    Inoue, Satoshi
    Horie, Kuniko
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 624 : 81 - 88
  • [30] Effect of mTOR inhibition on sensitivity of triple-negative breast cancer cells to epidermal growth factor inhibition
    Liu, T.
    Yacoub, R.
    Graham, T.
    Yang, L.
    Tighiouart, M.
    O'Regan, R. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345